{"companyId":78597,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"Gyre Therapeutics, Inc.","headOfficeLocation":"シアトル、ワシントン州、アメリカ合衆国","presidentName":"ルオユ・チェン","companySummary":null,"stockCode":"GYRE","currency":null,"capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["gyretx.com"],"businessContents":["臓器線維症のための医薬品開発","特発性肺線維症に対するピルフェニドンを用いた治療法","がんや炎症性疾患のための標的タンパク質分解促進剤および分解促進抗体結合療法"],"relations":[{"detailNumber":1,"relationCompanyName":"Cullgen Inc.","relationCompanyId":78599,"url":null,"linkUrl":null,"remarks":null,"lastCheckDate":"2026-04-27","raGroup":70,"raParent":0,"raChild":70,"raCustomer":0,"raSupplier":0,"raPartnership":0,"raFinance":0,"raInvest":0}],"dataSources":[{"detailNumber":1,"url":"https://www.gyretx.com/about/","scoreAbout":68,"scoreBusiness":11,"scoreGroup":11,"scoreCustomer":3},{"detailNumber":2,"url":"https://www.gyretx.com/","scoreAbout":50,"scoreBusiness":16,"scoreGroup":11,"scoreCustomer":3}]}